0001062993-22-009446.txt : 20220404 0001062993-22-009446.hdr.sgml : 20220404 20220404163318 ACCESSION NUMBER: 0001062993-22-009446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans Elizabeth E. CENTRAL INDEX KEY: 0001863447 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38624 FILM NUMBER: 22802797 MAIL ADDRESS: STREET 1: C/O VACCINEX, INC. STREET 2: 1895 MOUNT HOPE AVENUE CITY: ROCHESTER STATE: NY ZIP: 14620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VACCINEX, INC. CENTRAL INDEX KEY: 0001205922 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161603202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 BUSINESS PHONE: 585-271-2700 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 FORMER COMPANY: FORMER CONFORMED NAME: VACCINEX INC DATE OF NAME CHANGE: 20021114 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-04-01 0001205922 VACCINEX, INC. VCNX 0001863447 Evans Elizabeth E. C/O VACCINEX, INC. 1895 MOUNT HOPE AVENUE ROCHESTER NY 14620 0 1 0 0 Chief Operating Officer Common Stock 9600 D Stock Option (Right to Buy) 7.1 2025-12-22 Common Stock 9610 9610 D Stock Option (Right to Buy) 7.1 2025-12-23 Common Stock 8605 8605 D Stock Option (Right to Buy) 3.9 2029-03-14 Common Stock 12400 12400 D Stock Option (Right to Buy) 3.82 2030-04-04 Common Stock 10000 10000 D Stock Option (Right to Buy) 2.93 2031-04-03 Common Stock 8000 8000 D Stock Option (Right to Buy) 1.29 2022-04-01 4 A 0 20000 0 A 2032-04-01 Common Stock 20000 20000 D This option is fully exercisable as of the date of this report. This option has vested with respect to 9,300 shares and the remainder vests on March 15, 2023. This option has vested with respect to 5,000 shares and the remainder vests in two equal annual installments beginning on April 3, 2023. This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date. This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date. /s/ Scott E. Royer, Attorney-in-Fact for Elizabeth E. Evans 2022-04-04